Acrux has developed and commercialised through licensees a number of topically applied pharmaceutical products in the US and Europe|Michael Kotsanis , CEO of Acrux Limited 00:10:00

Share On Facebook Share On Twitter

Michael has more than 30 years of experience in the global pharmaceutical industry including significant senior leadership experience.

Recent Videos